Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (361-370 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary EventsM Cohen, C Demers, E P Gurfinkel, et al.
The New England Journal of Medicine|July 22, 1999
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb InvestigatorsJ S Hochman, J E Tamis, T D Thompson, et al.
Journal of the American College of Cardiology|October 1, 1989
Painless exercise ST deviation on the treadmill: long-term prognosisD B Mark, M A Hlatky, R M Califf, et al.
Circulation|April 1, 1998
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial InvestigatorsD J Kereiakes, A M Lincoff, D P Miller, et al.
The American Journal of Cardiology|April 1, 1988
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
Journal of the American College of Cardiology|May 1, 1988
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarctionD J Kereiakes, E J Topol, B S George, et al.
Circulation|May 1, 1988
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trialR M Califf, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 12, 2001
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionM T Roe, E M Ohman, A C Maas, et al.
Journal of the American College of Cardiology|June 13, 2001
Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?W J Cantor, A S Hellkamp, E D Peterson, et al.
Archives of Internal Medicine|July 22, 1996
Factors associated with change in resuscitation preference of seriously ill patients. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of TreatmentsK E Rosenfeld, N S Wenger, R S Phillips, et al.
Pageof 57

Showing results (361-370 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary EventsM Cohen, C Demers, E P Gurfinkel, et al.
The New England Journal of Medicine|July 22, 1999
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb InvestigatorsJ S Hochman, J E Tamis, T D Thompson, et al.
Journal of the American College of Cardiology|October 1, 1989
Painless exercise ST deviation on the treadmill: long-term prognosisD B Mark, M A Hlatky, R M Califf, et al.
Circulation|April 1, 1998
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial InvestigatorsD J Kereiakes, A M Lincoff, D P Miller, et al.
The American Journal of Cardiology|April 1, 1988
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
Journal of the American College of Cardiology|May 1, 1988
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarctionD J Kereiakes, E J Topol, B S George, et al.
Circulation|May 1, 1988
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trialR M Califf, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 12, 2001
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionM T Roe, E M Ohman, A C Maas, et al.
Journal of the American College of Cardiology|June 13, 2001
Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?W J Cantor, A S Hellkamp, E D Peterson, et al.
Archives of Internal Medicine|July 22, 1996
Factors associated with change in resuscitation preference of seriously ill patients. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of TreatmentsK E Rosenfeld, N S Wenger, R S Phillips, et al.
Pageof 57